COMMUNIQUÉS West-GlobeNewswire

Corcept Therapeutics Appoints Former Amgen Development Executive, Andreas Grauer, M.D., as Chief Medical Officer
18/03/2019
MENLO PARK, Calif., March 18, 2019 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of drugs to treat severe metabolic, oncologic [...]
Pulse8 extends the Utility and Technology of its powerful analytic engine, Illumin8 Active Intelligence™ platform
18/03/2019
NASHVILLE, March 18, 2019 (GLOBE NEWSWIRE) -- Pulse8, part of Veradigm™, an Allscripts (NASDAQ: MDRX) business unit, the first – and ONLY one with a patent pending – healthcare analytics and technology company [...]
Blissco Signs Supply Agreement with Alberta Gaming, Liquor and Cannabis (AGLC)
18/03/2019
Not for distribution in the U.S. or to U.S. Newswires VANCOUVER, British Columbia, March 18, 2019 (GLOBE NEWSWIRE) -- Blissco Cannabis Corp. ( CSE: BLIS ) ( OTCQB: HSTRF ) ( FRA: GQ4B ), (“Blissco”) or the (“Company”) [...]
CMR Surgical strengthens Board of Directors
18/03/2019
CMR Surgical Limited ("CMR Surgical" or the "Company") CMR Surgical strengthens Board of Directors Cambridge, UK, 18 March 2019 : CMR Surgical Ltd, the British company developing a next-generation surgical robot, today [...]
Daré Bioscience Announces Publication of Positive Clinical Findings for Vaginal Administration of Tamoxifen for the Treatment of VVA
18/03/2019
DARE-VVA1 is a proprietary formulation of tamoxifen for vaginal administration as a potential treatment for VVA in patients with hormone-receptor-positive breast cancer SAN DIEGO, March 18, 2019 (GLOBE NEWSWIRE) -- Daré [...]
VBI Vaccines to Present at the Oppenheimer 29th Annual Healthcare Conference
18/03/2019
CAMBRIDGE, Mass., March 18, 2019 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. (NASDAQ: VBIV) (“VBI”), a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines, [...]
Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results and Operational Highlights
18/03/2019
Phase 3 RECOVERY Trial of Tonmya® for the Treatment of PTSD Initiated and Enrolling Topline Data Expected First Half 2020 NEW YORK, March 18, 2019 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) ( [...]
Mapi Pharma Receives Government of Israel Funding for the Establishment of a Finished Dosage Form Facility for the Manufacturing of GA Depot Pharmaceuticals
18/03/2019
Plant will enable Mapi to supply the initial commercial needs of GA Depot NESS ZIONA, Israel, March 18, 2019 (GLOBE NEWSWIRE) -- Mapi Pharma Ltd., a fully integrated, clinical, late stage biopharmaceutical company, [...]
TYME Announces Leadership Team Update
18/03/2019
NEW YORK, March 18, 2019 (GLOBE NEWSWIRE) -- Tyme Technologies, Inc. (NASDAQ: TYME), an emerging biotechnology company developing cancer metabolism-based therapies, announced a realignment in responsibilities among its [...]
Tabula Rasa HealthCare Chief Strategic Growth Officer to Present at Innovation Showcase
18/03/2019
“Advancing Value through the Science of Personalized Medication Management” MOORESTOWN, N.J., March 18, 2019 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (NASDAQ: TRHC) Chief Strategic Growth Officer, Brian Litten, [...]
Cybrexa Therapeutics to Present First Data and Unveil Details for its alphalex™-PARP Inhibitor Lead Candidate CBX-11 at AACR Annual Meeting 2019
18/03/2019
NEW HAVEN, Conn., March 18, 2019 (GLOBE NEWSWIRE) -- Cybrexa Therapeutics, a biotechnology company developing a new class of cancer therapeutics through its alphalex™ tumor targeting platform, today announced that [...]
Emerald Health Therapeutics Appoints Vice President, Communications and Stakeholder Relations
18/03/2019
Allan Rewak brings extensive experience with government, media, communications and public affairs VICTORIA, British Columbia, March 18, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. ("Emerald" or the “ [...]
Soleno Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2018 Financial Results
18/03/2019
REDWOOD CITY, Calif., March 18, 2019 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, [...]
Paratek Pharmaceuticals Announces Management Change
18/03/2019
BOSTON, March 18, 2019 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a commercial-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics, today [...]
The Joint Corp. Acquires Clinic in Los Angeles County
18/03/2019
- Accelerating Expansion of Company-Owned or Managed Clinics, Represents the Third Added to the Portfolio in 2019 - SCOTTSDALE, Ariz., March 18, 2019 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), a national [...]
MediWound to Host Fourth Quarter & Fiscal 2018 Financial Results Conference Call on March 25 at 8:30 a.m. Eastern Time
18/03/2019
YAVNE, Israel, March 18, 2019 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and wound management, [...]
Tauriga Sciences, Inc. Receives Initial $54,000 Tauri-Gum Purchase Order from Major New York City Based Distributor
18/03/2019
NEW YORK, NY, March 18, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Tauriga Sciences, Inc. (OTCQB: TAUG ) (“Tauriga” or the “Company”), engaged in building its business through the development, distribution, and [...]
Medovex Corporation Receives an Additional $1.25 Million Under Existing Securities Purchase Agreement
18/03/2019
Increases Maximum Offering Size from $6M to $8M ALPHARETTA, Ga., March 18, 2019 (GLOBE NEWSWIRE) -- Medovex Corporation (OTCQB: MDVX) (“Medovex” or the “Company”) today announced that on March 11, 2019, the Company [...]
Radius Health to Present Data on TYMLOS® (abaloparatide) Injection at ENDO 2019 Annual Meeting
18/03/2019
WALTHAM, Mass., March 18, 2019 (GLOBE NEWSWIRE) -- Radius Health, Inc. (Nasdaq: RDUS), a science-driven fully integrated biopharmaceutical company that is committed to developing and commercializing innovative endocrine [...]

Pages